4//SEC Filing
Lang James Paul 4
Accession 0001628280-24-027709
CIK 0001448431other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 5:46 PM ET
Size
8.9 KB
Accession
0001628280-24-027709
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Lang James Paul
Director
Transactions
- Award
Common Stock
2024-06-07+13,286→ 68,044 total - Exercise/Conversion
Restricted Stock Units
2024-06-05−10,061→ 0 total→ Common Stock (10,061 underlying) - Exercise/Conversion
Common Stock
2024-06-05+10,061→ 54,758 total
Footnotes (3)
- [F1]Restricted stock units convert into common stock on a one-for-one basis
- [F2]Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on the earlier of the first anniversary of the date of grant or the date of the Company's next annual meeting of shareholders.
- [F3]On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001703090
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 5:46 PM ET
- Size
- 8.9 KB